Evaluation and testing services (ETS) for vaccines and other biologics for infectious diseases.
Active Indefinite Delivery Contract Awarded
- Contract number
- 75N93025D00021
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Evaluation and testing services (ETS) for vaccines Solicitation · Posted Jun 21, 2024
- Last date to order 11% complete
- IDV ceiling
- $136,588,701.00
- Maximum order
- $136,588,701.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 37 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract, valued at a ceiling of $136,588,701, is for evaluation and testing services (ETS) for vaccines and other biologics for infectious diseases.
The contract is a single-award indefinite delivery vehicle with a period of performance from September 30, 2025 to September 29, 2035. Lovelace Biomedical Research Institute will provide a wide range of scientific services under this contract, including animal studies, analytical testing, disease model development, inhalation toxicology research, medical countermeasure testing, and preclinical product development across various therapeutic areas. The contract does not have any set-aside requirements. Lovelace has previously held multiple significant federal contract IDV awards from agencies such as the National Institutes of Health, Food and Drug Administration, Department of Defense, and Office of the Assistant Secretary for Preparedness and Response, demonstrating its expertise in supporting complex federal research and development needs.
Quick answers
Who was awarded contract 75N93025D00021?
75N93025D00021 was awarded to Lovelace Biomedical Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2025.
How much is contract 75N93025D00021 worth?
75N93025D00021's own ceiling is $136,588,701. A single order can be worth up to $136,588,701.
Who can order from contract 75N93025D00021?
75N93025D00021 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93025D00021 competed?
The extent of competition for 75N93025D00021 was full and open competition. The government received 37 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV